Mary Ann Cloyd Ekso Bionics Holdings, Inc. (EKSO) insider trading activity

EKSO Quotes by TradingView

Mary Ann Cloyd is Director of EKSO BIONICS HOLDINGS, INC.. Currently has a direct ownership of 220,505 shares of EKSO, which is worth approximately $264,606. The most recent transaction as insider was on Jun 06, 2024, when has been sold 78,217 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K
0% 3M change
49.1% 12M change
Total Value Held $264,606

Mary Ann Cloyd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
78,217 Added 26.18%
220,505 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
72,993 Added 33.05%
147,889 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
51,721 Added 40.85%
74,896 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
18,265 Added 44.08%
23,175 Common Stock
Feb 18 2021
BUY
Grant, award, or other acquisition
-
4,910 Added 50.0%
4,910 Common Stock

Also insider at

FDP
FRESH DEL MONTE PRODUCE INC Consumer Defensive
Director
BLPH
Bellerophon Therapeutics, Inc. Healthcare
Director
MAC

Mary Ann Cloyd

Director
Coral Gables, FL

Track Institutional and Insider Activities on EKSO

Follow EKSO BIONICS HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EKSO shares.

Notify only if

Insider Trading

Get notified when an Ekso Bionics Holdings, Inc. insider buys or sells EKSO shares.

Notify only if

News

Receive news related to EKSO BIONICS HOLDINGS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EKSO